Novo Nordisk today announced 2024 earnings, reporting a 26% increase in annual sales to ~$40.56bn. Read why I upgrade NVO ...

Novo Nordisk stock gains as it reports better-than-expected fourth-quarter 2024 results driven by strong sales of Diabetes ...

The Business Research Company Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

The Business Research Company Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

For many patients with type 2 diabetes, having to inject basal insulin every day is a burdensome fact of life, but Novo Nordisk is trying ... up at mealtimes with fast-acting insulins.

Welcome to the full-year 2024 Novo Nordisk earnings conference call. [Operator instructions] Please be advised that today's ...

Novo Nordisk—the foundation-run, conscience-stricken insulin company—seemed, from the outside, to be acting less like a research hospital and more like a corporation that had hit the heel of ...

Eli Lilly’s big-selling insulin ... In the meantime, Novo Nordisk has responded to the threat from the cut-price fast and long-acting insulins with newer insulins that aim to improve on the ...

Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind schedule ...

NDA accepted for review Zynquista (Lexicon Pharmaceuticals) Dual sodium-glucose co-transporter types 1 and 2 inhibitor As an adjunct to insulin ... semaglutide (Novo Nordisk) Long-acting amylin ...

Walmart teamed up with drugmaker Novo Nordisk to sell its ... like to purchase regular (short-acting), NPH (intermediate-acting), or premixed NPH/regular insulin without a prescription.” ...

He's also a former group vice president at Eli Lilly and later a vice president at Novo Nordisk ... Humalog, an injectable, fast-acting insulin to treat diabetes, became the first rDNA-derived ...